The dynamic bio-pharmaceutical and medical device companies are accelerating their medical affairs function scope beyond a traditional support function. The function manages strategic responsibilities bridging research as well as clinical development, its scientific publications strategy and utilizes health outcomes, biostatistics, necessary medical education and other medical services.
The medical affairs function enhances a company’s scientific reputation and complements the work of Research & Development. It also provides physicians, key opinion leaders (KOLs), legal-regulatory agencies, professional groups and healthcare professionals with medical and scientific information and education on the value and proper use of a company’s products, therapies, devices, technology and diagnostics.
These excellence services, provided by Best Practices, LLC, allow executives to gain strategic insight and successful approaches for competitive performance in medical affairs functions. The study lays key focus on gauging market attention, utilizing health outcomes, scientific publications strategy, educating physicians, key opinion leaders, patient advocacy and clinical developments.
The Medical Affairs Excellence Services is offers many options to the Medical Affairs executives seeking strategic insight and successful approaches. For more information and to create the right Excellence Services offering to meet your needs, please contact James Drake at (603) 410-3929 to learn more and to discuss pricing options.
Who Can Benefit From These Services?
These services provide valuable material for executives of the pharmaceutical organization to ensure superior execution and implementation of medical affairs strategy and drive operational efficiency. Executives will find numerous resource-related issues addressed, while the execution level managers will be able to create roadmaps and plans for accomplishing their objectives in key areas.
These services are geared for pharmaceutical executives with responsibilities in the areas of:
- Medical Affairs structuring and funding
- Post-marketing surveillance for adverse events
- Thought leaders relationships
- Pharmaceutical speaker programs - training and development
- Scientific Publications strategy
- Medical Science Liaisons
- Key Opinion Leader Relationships
- Collaborating with patient advocacy groups
- New Product Planning
- Webinars for enhancing key opinion leader relationships
- Educating the marketplace for new Product launches – oncology
